Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $126.7200 (1.7%) ($122.7700 - $127.8000) on Thu. Jul. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.04% (three month average) | RSI | 68 | Latest Price | $126.7200(1.7%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.8% a day on average for past five trading days. | Weekly Trend | LGND advances 2.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(50%) IWC(47%) IWM(47%) | Factors Impacting LGND price | LGND will decline at least -1.52% in a week (0% probabilities). VIXM(-22%) UUP(-16%) VXX(-15%) IYT(-4%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.52% (StdDev 3.04%) | Hourly BBV | 0 () | Intraday Trend | 3.2% | | | |
|
5 Day Moving Average | $123.51(2.6%) | 10 Day Moving Average | $123.37(2.72%) | 20 Day Moving Average | $119.31(6.21%) | To recent high | 0% | To recent low | 36.3% | Market Cap | $2.037b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |